Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Heidelberg University
University of South Florida
European Organisation for Research and Treatment of Cancer - EORTC